High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020–April 2021), Democratic Republic of the Congo
Emerging Infectious Diseases · 2023
DOI: 10.3201/eid2901.221009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2023. Verfasst von Yannick Munyeku-Bazitama und 14 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Serologic surveys are important tools for estimating the true burden of COVID-19 in a given population. After the first wave of SARS-CoV-2 infections, a household-based survey conducted in Kinshasa, Democratic Republic of the Congo, estimated >292 infections going undiagnosed for every laboratory-confirmed case. To ascertain the cumulative population exposure in Kinshasa after the second wave of COVID-19, we conducted a prospective population-based cross-sectional study using a highly sensitive and specific ELISA kit. The survey included 2,560 consenting persons from 585 households; 55% were female and 45% male. The overall population-weighted, test kit-adjusted SARS-CoV-2 seroprevalence was 76.5% (95% CI 74.5%-78.5%). The seroprevalence was 4-fold higher than during the first wave, and positivity was associated with age, household average monthly income, and level of education. Evidence generated from this population-based survey can inform COVID-19 response, especially vaccination campaign strategies in the context of vaccine shortages and hesitancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Munyeku-Bazitama, Y., Folefack, G. T., Yambayamba, M. K., Tshiminyi, P. M., Kazenza, B. M., Otshudiema, J. O., Guinko, N. T., Umba, M. D., Mulumba, A., Baketana, L. K., Mukadi, P. K., Smith, C., Muyembe-Tamfum, J. J., Ahuka-Mundeke, S., & Makiala-Mandanda, S. (2023). High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020–April 2021), Democratic Republic of the Congo. Emerging Infectious Diseases. https://doi.org/10.3201/eid2901.221009
Vancouver
Munyeku-Bazitama Y, Folefack GT, Yambayamba MK, Tshiminyi PM, Kazenza BM, Otshudiema JO, et al. High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020–April 2021), Democratic Republic of the Congo. Emerging Infectious Diseases. 2023. doi:10.3201/eid2901.221009
BibTeX
@article{MunyekuBazitama2023,
author = {Munyeku-Bazitama, Yannick and Folefack, Gervais T and Yambayamba, Marc K and Tshiminyi, Paul M and Kazenza, Benito M and Otshudiema, John O and Guinko, Noe Tondri and Umba, Moreau D and Mulumba, Anastasie and Baketana, Lionel K and Mukadi, Patrick K and Smith, Chris and Muyembe-Tamfum, Jean-Jacques and Ahuka-Mundeke, Steve and Makiala-Mandanda, Sheila},
title = {High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020–April 2021), Democratic Republic of the Congo},
journal = {Emerging Infectious Diseases},
year = {2023},
doi = {10.3201/eid2901.221009}
}
EUVIMED